<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">33419</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Chronic gout: causes, clinical manifestations, treatment</article-title><trans-title-group xml:lang="ru"><trans-title>Хроническая подагра: причины развития, клинические проявления, лечение</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Barskova</surname><given-names>Viktoriya Georgievna</given-names></name><name xml:lang="ru"><surname>Барскова</surname><given-names>Виктория Георгиевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>зав. отд; ГУ Институт ревматологии РАМН</p></bio><email>barskova@irramn.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Barskova</surname><given-names>V G</given-names></name><bio xml:lang="en"><p>Institute of Rheumatology, Russian Academy of Medical Sciences</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ГУ Институт ревматологии РАМН</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Rheumatology, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2010-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2010</year></pub-date><volume>82</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2010)</issue-title><issue-title xml:lang="ru">№1 (2010)</issue-title><fpage>64</fpage><lpage>68</lpage><history><date date-type="received" iso-8601-date="2020-04-13"><day>13</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2010, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2010, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/33419">https://ter-arkhiv.ru/0040-3660/article/view/33419</self-uri><abstract xml:lang="en"><p>Why chronic gout, that is mostly a well diagnosed and controlled disease if it is timely and systematically treated with allopurinol, becomes a topical public health problem following 50 years after the introduction of pathogenetic therapy with xantine oxidase inhibitors is under consideration. The principles of rational therapy for chronic gouty arthritis are outlined.</p></abstract><trans-abstract xml:lang="ru"><p>Рассмотрен вопрос о том, почему хроническая подагра, которая в большинстве случаев является хорошо диагностируемым и контролируемым заболеванием при своевременном и систематическом приеме аллопуринола, становится актуальной проблемой здравоохранения через 50 лет после внедрения в практику патогенетической терапии ингибиторами ксантиноксидазы. Изложены принципы рациональной терапии хронического подагрического артрита.</p></trans-abstract><kwd-group xml:lang="en"><kwd>chronic gout</kwd><kwd>chronic gouty arthritis</kwd><kwd>xantine oxidase inhibitors</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хроническая подагра</kwd><kwd>хронический подагрический артрит</kwd><kwd>ингибиторы ксантиноксидазы</kwd></kwd-group></article-meta></front><body></body><back><ref-list/></back></article>
